L2 Pharmacy Department, Investigational Drug Services Pharmacy, Brigham and Women's Hospital, Boston, MA 02115, USA.
Obes Surg. 2011 Sep;21(9):1477-81. doi: 10.1007/s11695-011-0455-5.
Bariatric surgical patients often need changes in formulation and dosages of their medications. The literature contains minimal information regarding pharmaceutical care and consultation services for the bariatric surgery patient. Complex medication regimens and safety concerns initiated a collaborative effort between surgeons and pharmacists to manage more effectively bariatric patients perioperatively. The consultation service included patient identification, pharmacy referral, pharmacist consultation with the patient, communication of recommendations with surgeons, follow-up, and documentation. There were 124 consultations performed from February 2, 2009 to December 1, 2010 with an average of 7.7 medications optimized per patient. Every patient required a minimum of one adjustment to their regimen. The surgeons approved 98% of these recommendations. Of recommendations provided, the majority focused on changing the formulation of the medication in some manner. The collaborative effort between surgeons and pharmacists effected changes in medication transitioning perioperatively and resulted in improved pharmaceutical care for this patient population.
肥胖症手术患者通常需要改变药物的配方和剂量。文献中关于肥胖症手术患者的药物治疗和咨询服务的信息很少。复杂的药物治疗方案和安全性问题促使外科医生和药剂师共同努力,以便在围手术期更有效地管理肥胖症患者。咨询服务包括患者识别、药房转介、药剂师与患者的咨询、与外科医生沟通建议、随访和记录。从 2009 年 2 月 2 日至 2010 年 12 月 1 日,共进行了 124 次咨询,每位患者平均优化了 7.7 种药物。每位患者的治疗方案都至少需要调整一次。外科医生批准了这些建议中的 98%。所提供的建议中,大多数侧重于以某种方式改变药物的配方。外科医生和药剂师之间的合作对围手术期的药物转换产生了影响,为这一患者群体提供了更好的药物治疗。